Editas Medicine to Host Conference Call Discussing First Quarter 2019 Results and Corporate Update by bizlift | Apr 30, 2019 | Editas Press Releases, Portfolio News
Allergan and Editas Medicine Announce Initial Data from Natural History Study to Evaluate Patients with Leber Congenital Amaurosis 10 (LCA10) by bizlift | Apr 29, 2019 | Editas Press Releases, Portfolio News
Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms by bizlift | Apr 3, 2019 | Editas Press Releases, Portfolio News
Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update by bizlift | Feb 28, 2019 | Editas Press Releases, Portfolio News
Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease Day® by bizlift | Feb 28, 2019 | Editas Press Releases, Portfolio News
